.RESEARCH FEATURE.06 August 2024.
A large randomized measured trial with cisgender ladies highlights the problems of fidelity to a daily dental preexposure treatment routine and demonstrates that twice-yearly injection of lenacapavir can preserve successful HIV prevention amounts over 6 months.